Health economic evaluation of an artificial intelligence (AI)-based rapid nutritional diagnostic system for hospitalised patients: A multicentre, randomised controlled trial

被引:0
|
作者
Sun, Ming-Yao [1 ,2 ]
Wang, Yu [1 ]
Zheng, Tian [2 ]
Wang, Xue [1 ]
Lin, Fan [2 ]
Zheng, Lu-Yan [2 ]
Wang, Mao-Yue [1 ]
Zhang, Pian-Hong [3 ]
Chen, Lu-Ying [3 ]
Yao, Ying [4 ]
Sun, Jie [4 ]
Li, Zeng-Ning [5 ,6 ,7 ]
Hu, Huan-Yu [5 ,6 ,8 ]
Jiang, Hua [8 ]
Yue, Han-Yang [8 ]
Zhao, Qian [9 ]
Wang, Hai-Yan [9 ]
Han, Lei [10 ]
Ma, Xuan [10 ]
Ji, Meng-Ting [10 ]
Xu, Hong-Xia [11 ]
Luo, Si-Yu [11 ]
Liu, Ying-Hua [12 ]
Zhang, Yong [12 ]
Han, Ting [13 ]
Li, Yan-Sheng [14 ]
Hou, Peng-Peng [14 ]
Chen, Wei [1 ]
机构
[1] Chinese Acad Med Sci Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Clin Nutr, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[2] Fujian Med Univ, Fuzhou Univ Affiliated Prov Hosp, Fujian Prov Hosp, Shengli Clin Med Coll,Dept Clin Nutr,Fujian Key La, Fuzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Clin Nutr, Hangzhou, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nutr, Wuhan, Peoples R China
[5] Hebei Med Univ, Hosp 1, Dept Clin Nutr, Shijiazhuang, Peoples R China
[6] Hebei Key Lab Nutr & Hlth, Shijiazhuang, Peoples R China
[7] Hebei Med Univ, Hosp Stomatol, Shijiazhuang, Peoples R China
[8] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Emergency & Disaster Med, Sichuan Acad Med Sci,Sch Med, Chengdu, Peoples R China
[9] Ningxia Hui Autonomous Reg Peoples Hosp, Dept Clin Nutr, Yinchuan, Peoples R China
[10] Qingdao Univ, Affiliated Hosp, Dept Clin Nutr, Qingdao, Chin, Myanmar
[11] Third Mil Med Univ, Daping Hosp, Dept Clin Nutr, Chongqing, Peoples R China
[12] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Nutr, Beijing, Peoples R China
[13] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Clin Nutr, Shanghai, Peoples R China
[14] DHC Mediway Technol Co Ltd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Artificial intelligence; Nutritional assessment; Incremental cost-effectiveness ratio; Randomised controlled trial; SUBJECTIVE GLOBAL ASSESSMENT; CLINICAL NUTRITION; MALNUTRITION;
D O I
10.1016/j.clnu.2024.08.030
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Malnutrition is prevalent among hospitalised patients, and increases the morbidity, mortality, and medical costs; yet nutritional assessments on admission are not routine. This study assessed the clinical and economic benefits of using an artificial intelligence (AI)-based rapid nutritional diagnostic system for routine nutritional screening of hospitalised patients. Methods: A nationwide multicentre randomised controlled trial was conducted at 11 centres in 10 provinces. Hospitalised patients were randomised to either receive an assessment using an AI-based rapid nutritional diagnostic system as part of routine care (experimental group), or not (control group). The overall medical resource costs were calculated for each participant and a decision-tree was generated based on an intention-to-treat analysis to analyse the cost-effectiveness of various treatment modalities. Subgroup analyses were performed according to clinical characteristics and a probabilistic sensitivity analysis was performed to evaluate the influence of parameter variations on the incremental cost-effectiveness ratio (ICER). Results: In total, 5763 patients participated in the study, 2830 in the experimental arm and 2933 in the control arm. The experimental arm had a significantly higher cure rate than the control arm (23.24% versus 20.18%; p 1/4 0.005). The experimental arm incurred an incremental cost of 276.52 CNY, leading to an additional 3.06 cures, yielding an ICER of 90.37 CNY. Sensitivity analysis revealed that the decisiontree model was relatively stable. Conclusion: The integration of the AI-based rapid nutritional diagnostic system into routine inpatient care substantially enhanced the cure rate among hospitalised patients and was cost-effective. Registration: NCT04776070 (https://clinicaltrials.gov/study/NCT04776070). (c) 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:2327 / 2335
页数:9
相关论文
共 48 条
  • [41] Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo- controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX-REVOLUTIOn trial
    Maia, Israel S.
    Marcadenti, Aline
    Veiga, Viviane C.
    Miranda, Tamiris A.
    Gomes, Samara P. C.
    Carollo, Mariana B. S.
    Negrelli, Karina L.
    Gomes, Jackeline O.
    Tramujas, Lucas
    Abreu-Silva, Erlon O.
    Westphal, Glauco A.
    Fernandes, Ruthy P.
    Horta, Jacques G. A.
    Oliveira, Deborah C.
    Flato, Uri A. P.
    Paoliello, Ricardo C. R.
    Fernandes, Camilo
    Zandonai, Cassio L.
    Coelho, Juliana C.
    Barros, Waldemar C.
    Lemos, Juliana C.
    Bolan, Renata S.
    Dutra, Marcela M.
    Gebara, Otavio C. E.
    Lopes, Ana T. A.
    Alencar Filho, Meton S.
    Arraes, Jussara A.
    Hamamoto, Victor A.
    Hernandes, Mauro E.
    Golin, Nicole A.
    Santos, Tiago M.
    Santos, Renato H. N.
    Damiani, Lucas P.
    Zampieri, Fernando G.
    Gesto, Joao
    Machado, Flavia R.
    Rosa, Regis G.
    Azevedo, Luciano C. P.
    Avezum, Alvaro
    Lopes, Renato D.
    Souza, Thiago M. L.
    Berwanger, Otavio
    Cavalcanti, Alexandre B.
    LANCET REGIONAL HEALTH-AMERICAS, 2023, 20
  • [42] EFFECTIVENESS AND SAFETY OF AN ARTIFICIAL INTELLIGENCE-BASED MEDICAL DECISION SUPPORT SYSTEM FOR ADJUSTING INSULIN PUMP SETTINGS IN CHILDREN WITH TYPE 1 DIABETES MELLITUS: RANDOMIZED CONTROLLED TRIAL
    Laptev, Dmitry N.
    Sorokin, Daniil Yu.
    Trufanova, Evgeniya S.
    Rebrova, Olga Yu.
    Bezlepkina, Olga B.
    DIABETES MELLITUS, 2024, 27 (03): : 254 - 264
  • [43] Effect of Artificial Intelligence-based Health Education Accurately Linking System (AI-HEALS) for Type 2 diabetes self-management: protocol for a mixed-methods study
    Wu, Yibo
    Min, Hewei
    Li, Mingzi
    Shi, Yuhui
    Ma, Aijuan
    Han, Yumei
    Gan, Yadi
    Guo, Xiaohui
    Sun, Xinying
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [44] Effect of Artificial Intelligence-based Health Education Accurately Linking System (AI-HEALS) for Type 2 diabetes self-management: protocol for a mixed-methods study
    Yibo Wu
    Hewei Min
    Mingzi Li
    Yuhui Shi
    Aijuan Ma
    Yumei Han
    Yadi Gan
    Xiaohui Guo
    Xinying Sun
    BMC Public Health, 23
  • [45] Effectiveness of a coordinated support system linking public hospitals to a health coaching service compared with usual care at discharge for patients with chronic low back pain: protocol for a randomised controlled trial
    Emma K. Ho
    Manuela L. Ferreira
    Adrian Bauman
    Paul W. Hodges
    Christopher G. Maher
    Milena Simic
    Rachael L. Morton
    Chris Lonsdale
    Qiang Li
    Melissa T. Baysari
    Anita B. Amorim
    Dragana Ceprnja
    Ornella Clavisi
    Mark Halliday
    Matthew Jennings
    Alice Kongsted
    Katherine Maka
    Kate Reid
    Tahlia Reynolds
    Paulo H. Ferreira
    BMC Musculoskeletal Disorders, 22
  • [46] Effectiveness of a coordinated support system linking public hospitals to a health coaching service compared with usual care at discharge for patients with chronic low back pain: protocol for a randomised controlled trial
    Ho, Emma K.
    Ferreira, Manuela L.
    Bauman, Adrian
    Hodges, Paul W.
    Maher, Christopher G.
    Simic, Milena
    Morton, Rachael L.
    Lonsdale, Chris
    Li, Qiang
    Baysari, Melissa T.
    Amorim, Anita B.
    Ceprnja, Dragana
    Clavisi, Ornella
    Halliday, Mark
    Jennings, Matthew
    Kongsted, Alice
    Maka, Katherine
    Reid, Kate
    Reynolds, Tahlia
    Ferreira, Paulo H.
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [47] Cardioprotective effect of saffron total glycoside tablets in patients with breast cancer receiving anthracycline-based chemotherapy: study protocol for a multicentre, randomised, parallel, double-blind, placebo-controlled clinical trial
    Su, Xin
    Li, Xiang-Ying
    Zhang, Yi-Jun
    Liu, Yong-Sheng
    Yuan, Chao
    Yang, Fan
    Liu, Can
    Chen, Heng-Wen
    Xiong, Xing-Jiang
    Gao, Yong-Hong
    Xing, Yan-Wei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 8283 - 8291
  • [48] Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer
    Mukherjee, Uma Anne
    Hockings, Helen
    Counsell, Nicholas
    Patel, Apini
    Narayanan, Priya
    Wilkinson, Katie
    Dhanda, Harjot
    Robinson, Kathy
    Mcneish, Iain
    Anderson, Alexander R. A.
    Miller, Rowan
    Gourley, Charlie
    Graham, Trevor
    Lockley, Michelle
    BMJ OPEN, 2024, 14 (12):